ERS Congress

Advertisement

cGxPJobs Banner

Celea Therapeutics Advances Phase 3 Deupirfenidone Program in IPF

August 24, 2026 | Boston, Massachusetts, USA Celea Therapeutics announced that it will present new clinical development updates for...

By cGxPwire Editor
August 26, 2026

Read More

Advertisement

cGxPJobs

Directory